Literature DB >> 8362071

Course and outcome in panic disorder.

M B Keller1, D L Hanks.   

Abstract

1. Panic disorder (PD) is an illness that can be acute or chronic and is often complicated by depression, phobias and obsessions. This illness affects at least 10% of the population. 2. Panic disorder has been recognized as a psychopathologic condition for at least 100 years. Over the last several decades, health professionals have changed their view of PD, and in 1987 the DSM-III included PD as a distinctive syndrome. 3. Several studies have shown PD to be a chronic illness with only little to no improvement in 36-40% of the subjects after 1 to 20 years of treatment. Studies also suggest that duration of illness affects the degree of impairment: subjects who had PD for more than 6 months showed more impairment that subjects who had PD for less than 6 months. 4. Several studies show that 50-75% of patients with PD have had at least one episode of major depression. Findings also indicate that subjects with both PD and secondary depression are a more severely ill group. 5. The HARP study is an ongoing 12-site naturalistic, longitudinal examination of patients with current or past PD. One of the major goals of this study is to describe the patterns of the clinical course of PD related disorders. 6. Clinical experience indicates that an estimated 40% of PD patients may need treatment for one year and between 20-40% will require continued maintenance treatment. Long-term treatment may include behavioral therapy and/or medication. 7. Anxiety disorders are common and familial and are consistently higher among women. Panic Disorder is a chronic condition frequently complicated by Axis I and II disorders. Continued long-term maintenance studies of medications and psychotherapy for anxiety disorders is critical in the treatment of this chronic illness.

Entities:  

Mesh:

Year:  1993        PMID: 8362071     DOI: 10.1016/0278-5846(93)90005-d

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


  3 in total

1.  CLINICAL CONSEQUENCES OF THE REVISED DSM-5 DEFINITION OF AGORAPHOBIA IN TREATMENT-SEEKING ANXIOUS YOUTH.

Authors:  Danielle Cornacchio; Tommy Chou; Hayley Sacks; Donna Pincus; Jonathan Comer
Journal:  Depress Anxiety       Date:  2015-04-04       Impact factor: 6.505

2.  The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods.

Authors:  Brenda W J H Penninx; Aartjan T F Beekman; Johannes H Smit; Frans G Zitman; Willem A Nolen; Philip Spinhoven; Pim Cuijpers; Peter J De Jong; Harm W J Van Marwijk; Willem J J Assendelft; Klaas Van Der Meer; Peter Verhaak; Michel Wensing; Ron De Graaf; Witte J Hoogendijk; Johan Ormel; Richard Van Dyck
Journal:  Int J Methods Psychiatr Res       Date:  2008       Impact factor: 4.035

3.  The development of agoraphobia is associated with the symptoms and location of a patient's first panic attack.

Authors:  Naomi Hara; Yukika Nishimura; Chika Yokoyama; Ken Inoue; Atsushi Nishida; Hisashi Tanii; Motohiro Okada; Hisanobu Kaiya; Yuji Okazaki
Journal:  Biopsychosoc Med       Date:  2012-04-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.